These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 12034170)
1. Combined use of FTY720 and cyclosporine A prevents chronic allograft vasculopathy. Koshiba T; Van Damme B; Lu Y; Yan Y; Rutgeerts O; Overbergh L; Tanaka K; Waer M; Mathieu C; Pirenne J Transplant Proc; 2002 May; 34(3):748-9. PubMed ID: 12034170 [No Abstract] [Full Text] [Related]
2. Immunosuppressive effect of a new drug, FTY720, on lymphocyte responses in vitro and cardiac allograft survival in rats. Suzuki S; Enosawa S; Kakefuda T; Li XK; Mitsusada M; Takahara S; Amemiya H Transpl Immunol; 1996 Sep; 4(3):252-5. PubMed ID: 8893458 [No Abstract] [Full Text] [Related]
3. Synergistic interaction of FTY720 with cyclosporine or sirolimus to prolong heart allograft survival. Stepkowski SM; Wang M; Qu X; Yu J; Okamoto M; Tejpal N; Kahan BD Transplant Proc; 1998 Aug; 30(5):2214-6. PubMed ID: 9723445 [No Abstract] [Full Text] [Related]
4. Rescuing acute rejection of rat cardiac allografts with FTY720. Chueh SC; Tsai CC; Chiu B; Li YC; Lai MK Transplant Proc; 2000 Nov; 32(7):1629-30. PubMed ID: 11119868 [No Abstract] [Full Text] [Related]
5. Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models. Nikolova Z; Hof A; Baumlin Y; Hof RP Transpl Immunol; 2001 Feb; 8(4):267-77. PubMed ID: 11316070 [TBL] [Abstract][Full Text] [Related]
6. FTY720 prevents chronic rejection of rat heterotopic cardiac allografts. Chueh SC; Chen JR; Chen J; Lai MK Transplant Proc; 2001; 33(1-2):542-3. PubMed ID: 11266948 [No Abstract] [Full Text] [Related]
7. FTY720 blocks allograft rejection by homing of lymphocytes in vivo. Yuzawa K; Stephkowski SM; Wang M; Kahan BD Transplant Proc; 2000 Mar; 32(2):269. PubMed ID: 10715413 [No Abstract] [Full Text] [Related]
8. Pretreatment with FTY720 alone induced long-term survival of mouse heart allograft. Zhang L; Zhu T; Sun EW; Shen SQ; Min ZL; Chen ZK Transplant Proc; 2003 Feb; 35(1):567-8. PubMed ID: 12591534 [No Abstract] [Full Text] [Related]
10. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus. Wang ME; Tejpal N; Qu X; Yu J; Okamoto M; Stepkowski SM; Kahan BD Transplantation; 1998 Apr; 65(7):899-905. PubMed ID: 9565092 [TBL] [Abstract][Full Text] [Related]
11. Tolerance induction with FTY720 and donor-specific blood transfusion: discrepancy between heart transplantation and intestinal transplantation. Koshiba T; Ji P; Tanaka K; McMaster P; Van Damme B; Waer M; Pirenne J Transplant Proc; 2000 Sep; 32(6):1255-7. PubMed ID: 10995936 [No Abstract] [Full Text] [Related]
12. Novel insights into the mechanism of action of FTY720 in a transgenic model of allograft rejection: implications for therapy of chronic rejection. Habicht A; Clarkson MR; Yang J; Henderson J; Brinkmann V; Fernandes S; Jurewicz M; Yuan X; Sayegh MH J Immunol; 2006 Jan; 176(1):36-42. PubMed ID: 16365393 [TBL] [Abstract][Full Text] [Related]
13. Effect of a new immunosuppressant, FTY720, on joint allografts. Watanabe H; Hamada Y; Toshima T; Nagasawa K; Sakano Y J Reconstr Microsurg; 1999 May; 15(4):295-8. PubMed ID: 10363553 [TBL] [Abstract][Full Text] [Related]
14. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts. Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767 [TBL] [Abstract][Full Text] [Related]
15. Donor-specific blood transfusion does not enhance the effect of FTY720 in rat cardiac allotransplantation. Antoniou EA; Drayson M; Howie AJ; McMaster P; D'Silva M Transplant Proc; 1998 Jun; 30(4):1042-3. PubMed ID: 9636420 [No Abstract] [Full Text] [Related]
16. Effect of FTY720 on rat small bowel transplantation. Fujishiro J; Inoue S; Shimizu H; Yoshino H; Murakami T; Kobayashi E Transplantation; 2004 Jun; 77(12):1910-1. PubMed ID: 15223918 [No Abstract] [Full Text] [Related]
17. Combined FTY720/cyclosporine treatment promotes graft survival and lowers the peripheral lymphocyte count in a murine cardiac allotransplantation model. Nikolova Z; Hof A; Baumlin Y; Hof RP Transplantation; 2001 Jul; 72(1):168-71. PubMed ID: 11468555 [TBL] [Abstract][Full Text] [Related]
18. Protective effects of FTY720 on chronic allograft nephropathy by reducing late lymphocytic infiltration. Wang M; Liu S; Ouyang N; Song E; Lutz J; Heemann U Kidney Int; 2004 Sep; 66(3):1248-56. PubMed ID: 15327424 [TBL] [Abstract][Full Text] [Related]
19. Donor pretreatment with FTY720 increases graft lymphocytes but does not affect graft survival following rat small bowel transplantation. Sakagawa T; Kiyochi H; Honda K; Kobayashi N Transplant Proc; 2002 May; 34(3):973-4. PubMed ID: 12034266 [No Abstract] [Full Text] [Related]
20. Effect of a novel immunosuppressant, FTY720, on heart and liver transplantations in rats. Yamashita K; Nomura M; Omura T; Takehara M; Suzuki T; Shimamura T; Kishida A; Furukawa H; Murakami M; Uede T; Todo S Transplant Proc; 1999; 31(1-2):1178-9. PubMed ID: 10083526 [No Abstract] [Full Text] [Related] [Next] [New Search]